Contact Us
Pulmonary Or Respiratory Drug Delivery Global Market Report 2025
Global Pulmonary Or Respiratory Drug Delivery Market Report 2025
Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Pulmonary Or Respiratory Drug Delivery Global Market Report 2025

By Product (Formulation Type, Device Type), By Canister Type (Plain Canister, Coated Canister), By Application (Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications), By End-User (Hospitals, Clinics, Home Care Settings) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pulmonary Or Respiratory Drug Delivery Market Overview

• Pulmonary Or Respiratory Drug Delivery market size has reached to $69.83 billion in 2024

• Expected to grow to $105.32 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Impact Of Rising Pneumonia Cases On The Growth Of Market

• Market Trend: Innovations In Complex Drug Delivery Systems Revolutionizing Pulmonary And Respiratory Treatments

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pulmonary Or Respiratory Drug Delivery Market?

Pulmonary or respiratory drug delivery refers to the administration of medication directly into the lungs to achieve rapid absorption, targeted treatment, and reduced systemic side effects for both local and systemic therapeutic effects.

The main product types of pulmonary or respiratory drug delivery are formulation type and device type. Formulation type refers to the preparation method used to administer drugs effectively, ensuring accurate dosing and absorption in the body. The various canister types include plain canisters and coated canisters. These are used for various applications such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and other conditions. These are also used for various end-users such as hospitals, clinics, and home care settings.

Pulmonary Or Respiratory Drug Delivery Market Size and growth rate 2025 to 2029: Graph

What Is The Pulmonary Or Respiratory Drug Delivery Market Size 2025 And Growth Rate?

The pulmonary or respiratory drug delivery market size has grown strongly in recent years. It will grow from $69.83 billion in 2024 to $75.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing prevalence of asthma, rising adoption of advanced inhalation devices, growth in healthcare expenditure globally, rising awareness of respiratory diseases, and rising incidence of allergic conditions.

What Is The Pulmonary Or Respiratory Drug Delivery Market Growth Forecast?

The pulmonary or respiratory drug delivery market size is expected to see strong growth in the next few years. It will grow to $105.32 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for personalized medicine, rising prevalence of chronic respiratory diseases, growing emphasis on telemedicine, increasing investments in healthcare infrastructure, and growth in e-commerce for pharmaceutical products. Major trends in the forecast period include advancements in particle engineering, development of advanced nebulizers, development of liposomal formulations, advancements in computational fluid dynamics, development of smart inhalers.

The forecast of 8.6% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. hospitals by increasing the cost of vibrating mesh nebulizers and smart inhaler technologies sourced from Sweden and Japan, thereby reducing treatment efficacy and elevating respiratory therapy equipment costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Pulmonary Or Respiratory Drug Delivery Market Segmented?

1) By Product: Formulation Type, Device Type

2) By Canister Type: Plain Canister, Coated Canister

3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications

4) By End-User: Hospitals, Clinics, Home Care Settings

Subsegments:

1) By Formulation Type: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), nebulizers, Liquid Aerosols, Nasal Sprays

2) By Device Type: Inhalers (Manual and Digital), Nebulizers (Compressor, Ultrasonic, Mesh), Breath-Activated Devices, Spacer Devices, Nasal Drug Delivery Devices

What Is Driving The Pulmonary Or Respiratory Drug Delivery Market? Impact Of Rising Pneumonia Cases On The Growth Of Market

The increasing prevalence of pneumonia is expected to propel the growth of the pulmonary or respiratory drug delivery market going forward. Pneumonia is a lung infection that causes inflammation of the air sacs, which may fill with fluid or pus, leading to symptoms like cough, fever, and difficulty breathing. The increasing prevalence of pneumonia such as aging populations, weakened immune systems, respiratory infections, air pollution, smoking, and the rise of antibiotic-resistant bacteria. Pulmonary or respiratory drug delivery helps pneumonia patients by directly targeting the lungs with medications, such as antibiotics, bronchodilators, or anti-inflammatory agents, enabling faster and more effective treatment to alleviate symptoms, reduce inflammation, clear infections, and improve respiratory function, ultimately enhancing recovery and preventing complications. For instance, in November 2023, according to the Centre for Tropical Medicine and Global Health, a UK-based leader in healthcare research, pneumonia cases in Kenya rose significantly, reaching 793,864 in 2022/2023. Therefore, the increasing prevalence of pneumonia drives the pulmonary or respiratory drug delivery industry.

Who Are The Major Players In The Global Pulmonary Or Respiratory Drug Delivery Market?

Major companies operating in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc

What Are The Key Trends Of The Global Pulmonary Or Respiratory Drug Delivery Market? Innovations In Complex Drug Delivery Systems Revolutionizing Pulmonary And Respiratory Treatments

Major companies operating in the pulmonary or respiratory drug delivery market are focusing on technological advancements such as complex drug delivery systems that enhance treatment efficacy and patient compliance. Complex drug delivery systems are advanced technologies that enhance the targeted delivery and controlled release of therapeutic agents, improving drug efficacy and patient outcomes. For instance, in July 2023, Viatris Inc., a US-based healthcare company that manufactures generic and branded medicines and Kindeva Drug Delivery L.P., a US-based company that offers drug delivery launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, an inhalation aerosol approved by the Food and Drug Administration, a US-based government agency. This is the first generic version of AstraZeneca's Symbicort and a metered-dose inhaler that combines budesonide and formoterol for treating asthma and chronic obstructive pulmonary disease. It is available in two strengths of 80 micrograms and 160 micrograms with 4.5 micrograms of formoterol.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Pulmonary Or Respiratory Drug Delivery Market? Kindeva Drug Delivery Acquires iPharma Labs Inc. To Strengthen Inhalation Therapy Development

In June 2022, Kindeva Drug Delivery, a US-based company that offers drug delivery solutions acquired iPharma Labs Inc. for an undisclosed amount. This acquisition enhances capabilities in inhalation therapy development, allowing for improved formulation and manufacturing processes for respiratory medications and enabling comprehensive support for pharmaceutical clients from early-stage development to commercial production. iPharma Labs Inc. is a US-based company that offers pulmonary or respiratory drug delivery solutions.

What Is The Regional Outlook For The Global Pulmonary Or Respiratory Drug Delivery Market?

North America was the largest region in the pulmonary or respiratory drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pulmonary Or Respiratory Drug Delivery Market?

The pulmonary or respiratory drug delivery market consists of sales of metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, aerosol formulations, and smart inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pulmonary Or Respiratory Drug Delivery Industry?

The pulmonary or respiratory drug delivery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary or respiratory drug delivery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Pulmonary Or Respiratory Drug Delivery Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $75.67 billion
Revenue Forecast In 2034 $105.32 billion
Growth Rate CAGR of 8.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The pulmonary or respiratory drug delivery market covered in this report is segmented –
1) By Product: Formulation Type, Device Type
2) By Canister Type: Plain Canister, Coated Canister
3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
4) By End-User: Hospitals, Clinics, Home Care Settings Subsegments:
1) By Formulation Type: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Nebulizers, Liquid Aerosols, Nasal Sprays
2) By Device Type: Inhalers (Manual and Digital), Nebulizers (Compressor, Ultrasonic, Mesh), Breath-Activated Devices, Spacer Devices, Nasal Drug Delivery Devices
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Pulmonary Or Respiratory Drug Delivery Market Characteristics

3. Pulmonary Or Respiratory Drug Delivery Market Trends And Strategies

4. Pulmonary Or Respiratory Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pulmonary Or Respiratory Drug Delivery Growth Analysis And Strategic Analysis Framework

5.1. Global Pulmonary Or Respiratory Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pulmonary Or Respiratory Drug Delivery Market Growth Rate Analysis

5.4. Global Pulmonary Or Respiratory Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pulmonary Or Respiratory Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pulmonary Or Respiratory Drug Delivery Total Addressable Market (TAM)

6. Pulmonary Or Respiratory Drug Delivery Market Segmentation

6.1. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Formulation Type

Device Type

6.2. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plain Canister

Coated Canister

6.3. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Obstructive Pulmonary Disease

Asthma

Cystic Fibrosis

Other Applications

6.4. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Home Care Settings

6.5. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Formulation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dry Powder Inhalers (DPIs)

Metered Dose Inhalers (MDIs)

Nebulizers

Liquid Aerosols

Nasal Sprays

6.6. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Device Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inhalers (Manual and Digital)

Nebulizers (Compressor, Ultrasonic, Mesh)

Breath-Activated Devices

Spacer Devices

Nasal Drug Delivery Devices

7. Pulmonary Or Respiratory Drug Delivery Market Regional And Country Analysis

7.1. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market

8.1. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pulmonary Or Respiratory Drug Delivery Market

9.1. China Pulmonary Or Respiratory Drug Delivery Market Overview

9.2. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pulmonary Or Respiratory Drug Delivery Market

10.1. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pulmonary Or Respiratory Drug Delivery Market

11.1. Japan Pulmonary Or Respiratory Drug Delivery Market Overview

11.2. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pulmonary Or Respiratory Drug Delivery Market

12.1. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pulmonary Or Respiratory Drug Delivery Market

13.1. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pulmonary Or Respiratory Drug Delivery Market

14.1. South Korea Pulmonary Or Respiratory Drug Delivery Market Overview

14.2. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pulmonary Or Respiratory Drug Delivery Market

15.1. Western Europe Pulmonary Or Respiratory Drug Delivery Market Overview

15.2. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pulmonary Or Respiratory Drug Delivery Market

16.1. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pulmonary Or Respiratory Drug Delivery Market

17.1. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pulmonary Or Respiratory Drug Delivery Market

18.1. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pulmonary Or Respiratory Drug Delivery Market

19.1. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pulmonary Or Respiratory Drug Delivery Market

20.1. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market

21.1. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market Overview

21.2. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pulmonary Or Respiratory Drug Delivery Market

22.1. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pulmonary Or Respiratory Drug Delivery Market

23.1. North America Pulmonary Or Respiratory Drug Delivery Market Overview

23.2. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pulmonary Or Respiratory Drug Delivery Market

24.1. USA Pulmonary Or Respiratory Drug Delivery Market Overview

24.2. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pulmonary Or Respiratory Drug Delivery Market

25.1. Canada Pulmonary Or Respiratory Drug Delivery Market Overview

25.2. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pulmonary Or Respiratory Drug Delivery Market

26.1. South America Pulmonary Or Respiratory Drug Delivery Market Overview

26.2. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pulmonary Or Respiratory Drug Delivery Market

27.1. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pulmonary Or Respiratory Drug Delivery Market

28.1. Middle East Pulmonary Or Respiratory Drug Delivery Market Overview

28.2. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pulmonary Or Respiratory Drug Delivery Market

29.1. Africa Pulmonary Or Respiratory Drug Delivery Market Overview

29.2. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape And Company Profiles

30.1. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape

30.2. Pulmonary Or Respiratory Drug Delivery Market Company Profiles

30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Pulmonary Or Respiratory Drug Delivery Market Other Major And Innovative Companies

31.1. 3M Company

31.2. Koninklijke Philips N.V.

31.3. GlaxoSmithKline

31.4. Omron Corporation

31.5. Teva Pharmaceutical Industries Ltd.

31.6. Aptar Pharma

31.7. Sumitomo Pharma America Inc.

31.8. Chiesi Farmaceutici S.p.A.

31.9. Cipla Inc.

31.10. Boehringer Ingelheim GmbH

31.11. Kindeva Drug Delivery Limited

31.12. Nemera Group

31.13. Hovione

31.14. H And T Presspart Group

31.15. Vectura Group plc

32. Global Pulmonary Or Respiratory Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pulmonary Or Respiratory Drug Delivery Market

34. Recent Developments In The Pulmonary Or Respiratory Drug Delivery Market

35. Pulmonary Or Respiratory Drug Delivery Market High Potential Countries, Segments and Strategies

35.1 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Countries Offering Most New Opportunities

35.2 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Segments Offering Most New Opportunities

35.3 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Formulation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Device Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Pulmonary Or Respiratory Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Pulmonary Or Respiratory Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Merck & Co. Inc. Financial Performance
  • Table 78: Novartis AG Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: AstraZeneca plc Financial Performance
  • Table 81: Abbott Laboratories Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Formulation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Device Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Pulmonary Or Respiratory Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Pulmonary Or Respiratory Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Merck & Co. Inc. Financial Performance
  • Figure 78: Novartis AG Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: AstraZeneca plc Financial Performance
  • Figure 81: Abbott Laboratories Financial Performance

Frequently Asked Questions

Pulmonary or respiratory drug delivery refers to the administration of medication directly into the lungs to achieve rapid absorption, targeted treatment, and reduced systemic side effects for both local and systemic therapeutic effects. For further insights on this market, request a sample here

The market major growth driver - Impact Of Rising Pneumonia Cases On The Growth Of Market. For further insights on this market, request a sample here

The pulmonary or respiratory drug delivery market size has grown strongly in recent years. It will grow from $69.83 billion in 2024 to $75.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increasing prevalence of asthma, rising adoption of advanced inhalation devices, growth in healthcare expenditure globally, rising awareness of respiratory diseases, and rising incidence of allergic conditions. The pulmonary or respiratory drug delivery market size is expected to see strong growth in the next few years. It will grow to " $105.32 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising demand for personalized medicine, rising prevalence of chronic respiratory diseases, growing emphasis on telemedicine, increasing investments in healthcare infrastructure, and growth in e-commerce for pharmaceutical products. Major trends in the forecast period include advancements in particle engineering, development of advanced nebulizers, development of liposomal formulations, advancements in computational fluid dynamics, development of smart inhalers. For further insights on this market, request a sample here

The pulmonary or respiratory drug delivery market covered in this report is segmented –
1) By Product: Formulation Type, Device Type
2) By Canister Type: Plain Canister, Coated Canister
3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
4) By End-User: Hospitals, Clinics, Home Care Settings Subsegments:
1) By Formulation Type: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Nebulizers, Liquid Aerosols, Nasal Sprays
2) By Device Type: Inhalers (Manual and Digital), Nebulizers (Compressor, Ultrasonic, Mesh), Breath-Activated Devices, Spacer Devices, Nasal Drug Delivery Devices For further insights on this market,
request a sample here

North America was the largest region in the pulmonary or respiratory drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary or respiratory drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc . For further insights on this market, request a sample here.

Major trends in this market include Innovations In Complex Drug Delivery Systems Revolutionizing Pulmonary And Respiratory Treatments. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon